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Summary
ToxR of Vibrio cholerae directly activates the ompU
promoter, but requires a second activator, TcpP to
activate the toxT promoter. ompU encodes a porin,
while toxT encodes the transcription factor, ToxT,
which activates V. cholerae virulence genes including
cholera toxin and the toxin co-regulated pilus. Using
an ompU-sacB transcriptional fusion, toxR mutant
alleles were identified that encode ToxR molecules
defective for ompU promoter activation. Many toxR
mutants defective for ompU activation affected resi-
dues involved in DNA binding. Mutants defective for
ompU activation were also tested for activation of the
toxT promoter. ToxR-F69A and ToxR-V71A, both in
the a-loop of ToxR, were preferentially defective for
ompU activation, with ToxR-V71A nearly completely
defective. Six mutants from the ompU-sacB selection
showed more dramatic defects in toxT activation than
ompU activation. All but one of the affected residues
map to the wing domain of the winged helix–turn–
helix of ToxR. Some ToxR mutants preferentially
affecting toxT activation had partial DNA-binding
defects, and one mutant, ToxR-P101L, had altered
interactions with TcpP. These data suggest that while
certain residues in the a-loop of ToxR are utilized to
activate the ompU promoter, the wing domain of ToxR
contributes to both promoter binding and ToxR/TcpP
interaction facilitating toxT activation.
Introduction
Vibrio cholerae is the causative agent of the diarrheal
disease cholera, a disease estimated to affect 18 million
people each year worldwide (WHO, 2003). V. cholerae
lives in aquatic environments year-round, but during sea-
sonal outbreaks the bacterium is ingested by humans in
contaminated food or water. Following ingestion, V. chol-
erae senses the changes in environmental conditions and
responds by activating a number of genes whose prod-
ucts are required for effective colonization and pathogen-
esis in human hosts. These include the genes encoding
cholera toxin and the toxin co-regulated pilus among
others (Mekalanos et al., 1983; Taylor et al., 1987; Levine
et al., 1988; Peterson and Mekalanos, 1988). Activation of
these virulence genes is dependent upon two inner mem-
brane localized transcription factors ToxR and TcpP (Miller
and Mekalanos, 1984; Miller et al., 1987; Carroll et al.,
1997; Häse and Mekalanos, 1998). Both ToxR and TcpP
have C-terminal periplasmic domains with the potential to
sense environmental signals as well as N-terminal DNA
binding and transcription activation domains similar to the
winged helix–turn–helix (winged-HTH) family of transcrip-
tion factors (Martinez-Hackert and Stock, 1997). ToxR and
TcpP stimulate virulence gene expression by combining to
activate the toxT promoter (Häse and Mekalanos, 1998;
Murley et al., 1999; Krukonis et al., 2000). ToxT then acti-
vates various virulence genes directly (DiRita et al., 1991;
Yu and DiRita, 2002; Withey and DiRita, 2006).
DNAse I footprinting studies, toxT promoter mutations
and analysis of a series of tcpP mutants have suggested
that TcpP directly interacts with RNA polymerase at the
toxT promoter while ToxR serves an accessory role from
a position further upstream of the basal promoter ele-
ments (Krukonis et al., 2000; Krukonis and DiRita, 2003;
Goss et al., 2010). Furthermore, it has been demon-
strated that TcpP and ToxR physically interact and that
this interaction may contribute to the activity of ToxR on
the toxT promoter (Krukonis and DiRita, 2003). In fact, a
mutant derivative of TcpP that is deficient in toxT promoter
binding (TcpP-H93L) is still functional for toxT activation if
ToxR is coexpressed (Krukonis et al., 2000). TcpP binds a
pentameric direct repeat element TGTAA-N6-TGTAA from
-53 to -38 relative to the start site of toxT transcription
(Goss et al., 2010). Within this repeat element, the central
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nucleotide of both repeats is critical for TcpP-mediated
toxT activation, even in the presence of ToxR (Goss et al.,
2010). These data lead to a model in which ToxR binds a
region upstream of the TcpP-binding site and facilitates
toxT promoter recognition and activation by TcpP (Goss
et al., 2010).
While both ToxR and TcpP are required for toxT activa-
tion (Higgins and DiRita, 1994; Champion et al., 1997;
Häse and Mekalanos, 1998), ToxR is able to regulate
other promoters in a TcpP-independent fashion. One
such promoter, ompU, controls expression of the outer
membrane porin OmpU. ToxR directly activates ompU
(Crawford et al., 1998) and represses expression of the
alternative porin, OmpT (Li et al., 2000). Proper regulation
of outer membrane protein synthesis is critical as expres-
sion of OmpT leads to greater sensitivity to bile and other
related detergents (Provenzano and Klose, 2000).
Given that ToxR directly activates ompU yet plays an
accessory role in toxT activation, we hypothesized that
the molecular mechanism by which ToxR regulates these
two promoters may be different and we might be able to
isolate point mutations in toxR that affect activation of
ompU or toxT specifically. Identification of such mutants
would strengthen the hypothesis that different regions of
ToxR are more critical for one type of activation or the
other, and based on homology to the winged-HTH family
of transcription factors, the position of mutant substitu-
tions may direct us to the function of certain domains of
ToxR. Precedent for such differential activation of the
ompU and toxT promoters comes from the fact that toxT
expression requires that ToxR be membrane-localized,
while ompU can be efficiently activated by a soluble form
of ToxR (Crawford et al., 2003).
In this study we identified residues in the a-loop of
ToxR, especially V71, as being critical for ompU promoter
activation, while several ToxR mutants had preferential
defects in toxT promoter activation, including six in the
wing domain of ToxR.
Results
We hypothesized that as ToxR appears to function by
different mechanisms at the ompU and toxT promoters,
we might be able to isolate toxR mutants that affect ompU
transcription, but not toxT. Identification of such mutants
would indicate which domain(s) of ToxR is critical to
directly activate transcription at the ompU promoter.
Isolation of toxR alleles defective for ompU activation
To isolate toxR mutants defective for ompU activation, an
ompU-sacB transcriptional fusion strain was constructed
in which an ompU-sacB fusion was inserted at the lacZ
locus of the DtoxR classical V. cholerae strain EK307
(EK406 derived from EK307; Table 1). The DtoxR ompU-
sacB selection strain is able to grow on 5% sucrose;
however, upon introduction of a wild-type copy of toxR on
a plasmid, this strain becomes sensitive to 5% sucrose. To
isolate toxR mutants, three pools of mutagenized toxR
alleles were introduced into EK406 by electroporation.
Transformants were plated on Luria–Bertani (LB) plates
containing 5% sucrose and colonies capable of grow-
ing on 5% sucrose were isolated. The toxR encoding
plasmids were sequenced, and selected mutants were
studied further.
In the course of constructing the toxR allele for PCR
mutagenesis, a C-terminal (periplasmic) HA-epitope tag
was added to the toxR coding sequence to allow assess-
ment of protein stability and translation with an anti-HA tag
antibody (Experimental procedures).
Quantification of ompU activation defects
Once candidate sucrose-resistant toxR alleles were iden-
tified that were defective for ompU activation, their protein
stability was assessed by anti-HA-epitope tag Western
blot analysis (data not shown) and alleles encoding full-
length ToxR derivatives were introduced into a V. cholerae
DtoxR ompU-lacZ reporter strain (EK410) to quantify
ompU activation defects. Like the ompU-sacB selection
strain the ompU-lacZ reporter was inserted at the lacZ
locus of V. cholerae (Crawford et al., 2003). The various
plasmid-encoded ToxR derivatives were tested for their
ability to activate ompU as compared with wild-type ToxR
or an empty vector control (pSK). Only mutants harbour-
ing a single amino acid substitution were studied further. If
a sequenced toxR allele defective for ompU activation
contained two or more mutations, the mutations were
separated by allelic exchange of a restriction fragment
into the parental plasmid pSK-toxR-HA or by site-directed
mutation. Following these reconstructions, 13 mutants
from the randomly mutagenized pools were studied. b-
galactosidase assays were performed and Miller Units for
wild-type ToxR were set at 100% and all mutant deriva-
tives were expressed relative to 100%.
Of these 13 ToxR derivatives, seven showed little or
no ability to activate the ompU promoter ( 3% wild-
type activity); ToxR-W64R, ToxR-V71A, ToxR-Q78R,
ToxR-L83P, ToxR-T99K, ToxR-T99R and ToxR-G104S,
although ToxR-L83P was somewhat less stable than the
other mutants (Fig. 1). The remaining six mutants retained
24–79% activity relative to wild-type ToxR.
Effect of ToxR substitutions on toxT activation
While the ToxR mutants were isolated based on their
reduced activation of the ompU promoter, we were also
interested in whether any mutants showed a differential
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effect on toxT activation. If the mechanism of ompU and
toxT activation differs, we expected to find some mutants
that were defective for ompU activation to be less affected
for toxT activation.
To examine the effect of ToxR substitutions on toxT
activation, the various plasmid-borne alleles were intro-
duced into the DtoxR toxT-lacZ reporter strain EK1072
(Table 1). Of the seven ToxR mutants that showed little
or no ompU-lacZ expression, all but mutant ToxR-V71A
showed little or no activity for toxT-lacZ expression as
well (Fig. 1). While many of these mutants may be
affected in their DNA-binding activity (see below), ToxR-
V71A seemed to be particularly interesting as it showed
only 3% activity on the ompU promoter, but maintained
15% activation of the toxT promoter (Fig. 1). This sug-
gests the ToxR-V71A mutation affects a region of ToxR
that is especially important for ToxR to directly activate
the ompU promoter, but less critical when ToxR plays an
accessory role with TcpP to activate the toxT promoter.
Based on homology with other winged-HTH proteins,
residue V71 of ToxR lies within the a-loop that is pro-
posed to directly interact with RNA polymerase to acti-
vate transcription of target promoters (Fig. 2A and B).
Thus, some mutations in this region of ToxR would be
predicted to affect the direct activation mechanism of
ToxR at the ompU promoter more than the accessory
role at the toxT promoter.
In addition to identifying mutant ToxR-V71A that affects
ompU activation more dramatically than toxT, six of the
ToxR mutants isolated were more strongly attenuated for
toxT activation than ompU. While this phenotype was not
necessarily expected from our selection strategy, we were
excited to identify such differential ToxR mutants. Again,
such mutants suggest that activation of ompU and toxT
by ToxR have different specific requirements within the
transcription activator ToxR. Five of six mutants lie just
N-terminal to or within the putative wing domain of the
ToxR winged-HTH structure; ToxR-D89E, ToxR-K92E,
ToxR-S93P, ToxR-P101L and ToxR-R103G (Fig. 2A and
C). The wing domain of winged-HTH proteins can perform
different functions including DNA binding and protein–
protein interaction, depending on the activator protein
(Littlefield and Nelson, 1999; Gajiwala et al., 2000; Blanco
et al., 2002; Krukonis and DiRita, 2003).
When the ToxR sequence is threaded onto the struc-
tures of related winged-HTH activator proteins (Fig. 2A),
five of the amino acid substitutions preferentially affecting
toxT expression are predicted to lie on a distinct face of
ToxR (Fig. 2C) from amino acids required for efficient
ompU activation in the a-loop (Fig. 2B). We did identify
one a-loop mutant, ToxR-R65Q, in the ompU-sacB screen
that was preferentially defective for toxT activation, but it
was the least preferential (< twofold differential, Figs 1
and 2C).
Table 1. Strains and plasmids.
Source
V. cholerae strain
EK307 O395 DtoxR Krukonis et al. (2000)
EK406 EK307 ompU-sacB This study
EK410 EK307 ompU-lacZ Crawford et al. (2003)
EK459 O395 DtoxRDtcpP Krukonis et al. (2000)
EK816 O395 DtoxRS toxT-lacZ This study
EK1072 EK307 toxT-lacZ This study
E. coli strain
DH5a lab strain
DHM1 Karimova et al. (2005)
BTH101 Karimova et al. (2001)
Plasmids
Random mutants from ompU-sacB
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Fig. 1. Activation of ompU-lacZ or toxT-lacZ chromosomal reporter constructs in V. cholerae by various ToxR mutant derivatives. DtoxR V.
cholerae strains were complemented with HA-tagged wild-type ToxR, the empty vector pSK Bluescript, or various ToxR mutant proteins.
b-galactosidase activity was measured after a 3–4 h induction with 100 mM IPTG at 30°C. Miller units were expressed as percent, relative to
activation seen with wild-type ToxR-HA. Data shown are from at least two experiments performed in triplicate. ToxR-HA from the same
samples used in the b-galactosidase assay was detected with an anti-HA antibody to assess protein stability.
Fig. 2. Modelling of the N-terminal DNA-binding/transactivation domain of ToxR (residues 1–114) using threading of the ToxR sequence onto
structurally related winged-HTH family members.
A. Labelling of putative domains of interest within the ToxR transcription activation and DNA-binding domain, model assembled using
I-TASSER (Zhang, 2008; 2009; Roy et al., 2010).
B. Homology modelling of residues within ToxR that affect ompU promoter activation more dramatically than toxT promoter activation.
C. Homology modelling of residues within ToxR that affect toxT promoter activation more dramatically than ompU promoter activation.
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A preliminary screen for ToxR mutants defective for
toxT-lacZ activation identified one additional mutant,
ToxR-K98E, preferentially affecting toxT activation (26%
of wild type) more than ompU activation (66% of wild type,
Table S1). This mutant was isolated using a blue/white
plate screen for toxT-lacZ activation (Supporting
information). ToxR-K98 also lies in the putative wing
domain of ToxR like most other toxT preferentially defec-
tive ToxR mutants.
Finally, a number of activation-defective ToxR mutants
have been identified previously. We assessed nine such
mutants (DiRita and Mekalanos, 1991; Ottemann et al.,
1992) for toxT and ompU activation (Table S1) and DNA
binding (Fig. S1). One mutant, ToxR-E39K, had a differ-
ential effect on activation. ToxR-E39K activated the
ompU promoter to 19% of wild-type ToxR, while it acti-
vated the toxT promoter at 105% of wild-type levels
(Table S1). This residue is thought to play a structural
role in domain packing of the winged-HTH domain of
PhoB/OmpR family members (Martínez-Hackert and
Stock, 1997; Okamura et al., 2000; Blanco et al., 2002),
but may also influence ToxR/RNAP interaction at the
ompU promoter (Fig. 2B).
DNA-binding activity of ToxR mutant derivatives
Six of the 13 isolated ToxR mutants were severely defec-
tive for activation of both the ompU and toxT promoters.
These include ToxR-W64R, ToxR-Q78R, ToxR-L83P,
ToxR-T99K, ToxR-T99R and ToxR-G104S. One simple
explanation for the defect in activation by these mutants is
that they fail to recognize either promoter. In fact, two of
the seven mutants lie within the putative DNA-recognition
helix (a3, Figs 1 and 2A) of ToxR (ToxR-Q78R and
ToxR-L83P).
We first assessed binding to the ompU promoter. V.
cholerae lacking endogenous copies of toxR and tcpP
(strain EK459, Table 1) was transformed with the pSK-
toxR-HA plasmid encoding each toxR mutant allele. Mem-
branes were prepared from these strains (Miller et al.,
1987) and used in a gel mobility shift assay with a radio-
labelled fragment of the ompU promoter from -211 to +22
relative to the transcription start site. This fragment has
been shown previously to contain ToxR-binding sites
(Crawford et al., 1998).
ompU promoter probes were mixed with 0.05 or
0.25 mg ml-1 of total membrane proteins. While negative
control membranes (pSK, vector alone) gave some
shifting of the probe in the absence of ToxR (Fig. 3A,
asterisk), ToxR-mediated binding could be distinguished
because ToxR causes retention of the probe in the well
(membranes are retained in the well in this assay,
Fig. 3A). This experiment demonstrated that the six
ToxR derivatives severely defective for both ompU and
toxT activation were unable to bind the ompU promoter.
These include ToxR-W64R, ToxR-Q78R, ToxR-L83P,
ToxR-T99K, ToxR-T99R and ToxR-G104S. To confirm
that sufficient amounts of ToxR were available to bind
the ompU promoter, Western blot analysis was per-
formed to determine the relative amount of each ToxR
derivative present in each gel-shift reaction. Levels of all
14 ToxR proteins (including wild type) were similar
(Fig. 3A). As a negative control probe for these experi-
ments we used a fragment of the toxT promoter lacking
a ToxR-binding site (from -46 to +45).
Most ToxR derivatives that demonstrated an intermedi-
ate ompU activation defect (Fig. 1) showed either modest
or no DNA-binding defect for the ompU promoter
(Fig. 3A). While ToxR-R65Q, ToxR-V71A and ToxR-K92E
were clearly not as efficient as wild-type ToxR for ompU
promoter binding (even with ToxR-K92E being present at
higher protein levels than wild-type ToxR), ToxR-P101L
and ToxR-R103G were somewhat less obvious in their
DNA-binding defects. Finally, ToxR-D89E and ToxR-S93P
bind the ompU promoter similar wild-type ToxR, although
ToxR-S93P does not retain all of the ompU probe in the
well (some smearing).
Because the ToxR derivatives with intermediate ompU
activation defects all have differential effects on toxT acti-
vation (Fig. 1), we examined whether these ToxR deriva-
tives have differential defects in toxT promoter binding as
compared with the ompU promoter. A toxT promoter
probe (from -172 to +45) containing the ToxR-binding site
was radiolabelled and used in a gel-shift assay with the
same membranes used for the ompU promoter gel-shift
assays (Fig. 3B). The six mutants defective for both ompU
and toxT activation (ToxR-W64R, ToxR-Q78R, ToxR-
L83P, ToxR-T99K, ToxR-T99R and ToxR-G104S) were
also defective for toxT promoter binding.
The two a-loop mutants, ToxR-R65Q and ToxR-V71A
showed intermediate defects in toxT promoter binding,
consistent with their ability to activate the toxT promoter to
15–20% of wild-type ToxR activity (Fig. 1).
The five ToxR mutants in the wing domain (or just
N-terminal to the wing) had intermediate toxT promoter-
binding defects (Fig. 3B). These wing and wing-proximal
mutants appear slightly more defective for toxT than
ompU promoter binding (Fig. 3A vs. Fig. 3B). However,
the level of their toxT activation defect is not solely deter-
mined by their DNA-binding defect. Specifically, ToxR-
P101L and ToxR-R103G have similar toxT promoter
DNA-binding defects, yet ToxR-R103G is threefold more
defective for toxT activation than ToxR-P101L. Thus, this
region may perform a role in addition to DNA binding that
affects toxT transcription activation. While ToxR-K92E
maintains some (albeit modest) DNA-binding activity on
the ompU and toxT promoters (Fig. 3), it has a much
stronger defect in toxT activation than ompU activation
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(Fig. 1). This could reflect a critical role for residue K92 in
toxT activation or the fact that toxT promoter activation is
more sensitive to ToxR mutations affecting DNA-binding
affinity. Finally, mutant ToxR-D89E showed nearly wild-
type binding to both the ompU and toxT promoters, with a
very slight defect in toxT binding (Fig. 3). This mutant can
only activate the toxT promoter to about 30% the level of
wild-type ToxR, while ompU activation shows 79% of
wild-type activity. This suggests this conservative amino
acid substitution is particularly detrimental to ToxR/TcpP-
mediated activation of the toxT promoter because of
either a slight defect in toxT promoter binding or some
other toxT activation function.
The role of a-loop residues on ompU and toxT
activation by ToxR
Because we found one ToxR residue essential for ompU
expression in the a-loop of ToxR, ToxR-V71 (Fig. 1), we
performed alanine-scanning mutagenesis of the entire the
Fig. 3. Gel-shift assays to assess promoter recognition by various ToxR mutant proteins identified in a random mutagenesis ompU-sacB
selection strategy. V. cholerae membranes prepared from a DtoxRDtcpP V. cholerae strain (EK459) expressing each mutant ToxR derivative
(or wild-type ToxR-HA) were mixed at 0.05 and 0.25 mg ml-1 (two lanes for each sample) with radiolabelled ompU promoter DNA (A) or 0.1
and 0.5 mg ml-1 with toxT promoter DNA (B) before running samples in a non-denaturing PAGE.
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putative a-loop (R65-S75). Mutations were constructed
in the pSK-toxR-HA vector and expressed in the either
the ompU-lacZ (EK410) or toxT-lacZ (EK1072) reporter
strains to assess transcription activation activity.
One additional mutant ToxR protein, ToxR-F69A,
showed a > twofold preferential defect for ompU
expression. It activated ompU-lacZ to 35% of wild-type
levels and toxT-lacZ to 92% of wild type (Table 2). Three
mutants, ToxR-R65A, ToxR-G68A and ToxR-S74A,
showed decreases in both ompU and toxT expression,
ToxR-G68A and ToxR-S74A being slightly more defective
for ompU than toxT activation (Table 2). One mutant
protein, ToxR-S75A, showed little or no activation of either
ompU or toxT. This residue approaches the predicted
DNA-binding helix of ToxR and disrupts the DNA-binding
activity of ToxR (see below).
One alanine mutant in the a-loop, ToxR-D73A, showed
a more dramatic defect on toxT (41% of wild type) than on
ompU (93% of wild type) expression. When residue D73
of ToxR is modelled onto homologous winged-HTH tran-
scription factor structures, ToxR residues F69 and V71 are
oriented away from the a-loop in one direction, while
residue D73 is predicted to be oriented in the opposite
direction, towards residues P101 and R103 (Fig. 2C). Our
random mutagenesis selection identified mutations in
these latter two residues, ToxR-P101L and ToxR-R103G,
which are also more dramatically affected for toxT expres-
sion than ompU. Thus, this face of the ToxR molecule
appears to play a critical role in toxT activation in conjunc-
tion with TcpP, while V71 and F69 of the a-loop are more
important for ompU activation by ToxR.
These alanine mutant studies also revealed that the
preferential defect of ToxR-R65Q on toxT activation
(Fig. 1) was largely side-chain-dependent as the ToxR-
R65A mutant had more similar defects in both ompU and
toxT activation (albeit still slightly more defective for toxT
activation, Table 2).
Promoter recognition by a-loop alanine mutants
Because some of our a-loop ToxR alanine mutants have
activation defects, we assessed the DNA-binding activity
of the various mutant proteins. Membranes were isolated
from a V. cholerae DtoxRDtcpP mutant (EK459) express-
ing various ToxR derivatives and the membrane prepara-
tions were used in gel-shift assays on the ompU (Fig. 4A)
or toxT (Fig. 4B) promoter.
While wild-type ToxR shifted about 50–75% of the
ompU probe at the lower membrane concentration
(Fig. 4A), three mutant proteins partially defective for
ompU activation (ToxR-R65A, ToxR-G68A and ToxR-
S74A; Table 2) had somewhat weaker binding to the
ompU promoter. ToxR-S75A is unable to activate either
the ompU or toxT promoter (Table 2) and is severely
defective for DNA binding (Fig. 4). Thus, it may define the
first residue of the DNA-binding helix of ToxR. Finally,
ToxR-F69A maintains wild-type levels of binding to the
ompU promoter (Fig. 4A) and displays slightly reduced
binding to the toxT promoter (Fig. 4B). However, ToxR-
F69A is preferentially defective for ompU activation
(Table 2). Thus, residue F69 (like V71 identified in our
original random mutagenesis selection) appears to be
particularly important for ToxR to directly activate RNAP at
the ompU promoter.
Effect of specific ToxR wing residue substitutions on
differential promoter activation
Because alanine-scanning mutagenesis of the a-loop
indicated some preferential defects were side-chain-
dependent (R65Q vs. R65A, Fig. 1 and Table 2), we
determined whether the preferential toxT activation
defects of certain ToxR wing mutants were due to the
specific side-chain substitutions, each residue was
mutated to alanine (ToxR-D89A, ToxR-K92A, ToxR-S93A,
Table 2. Activation phenotypes of ToxR a-loop mutants.
ToxR derivative location ompU-lacZ toxT-lacZ
ToxR-HA wild type – 100.0%  5.6 100.0%  6.9
pSK (vector) – 0.3%  0.03 1.6%  0.1
ToxR-R65A a-loop 51.3%  2.9 43.1%  1.4
ToxR-E66A a-loop 103.3%  4.6 106.4%  2.0
ToxR-Q67A a-loop 101.4%  3.6 164.5%  3.9
ToxR-G68A a-loop 12.0%  0.9 19.2%  2.3
ToxR-F69A a-loop 35.2%  1.1 91.6%  3.0
ToxR-E70A a-loop 79.5%  3.4 91.7%  3.1
ToxR-D72A a-loop 102.8%  2.5 118.0%  9.5
ToxR-D73A a-loop 92.9%  0.6 40.8%  15.3
ToxR-S74A a-loop 47.4%  5.1 63.1%  6.7
ToxR-S75A a-loop/DNA- binding domain 0.4%  0.02 4.5%  0.3
Miller units measured in strains EK410 (O395 DtoxR ompU-lacZ) and EK1072 (O395 DtoxR toxT-lacZ). Data are from one representative
experiment performed in triplicate.
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ToxR-K98A, ToxR-P101A and ToxR-R103A). These ToxR
derivatives were then tested for ompU and toxT activation
in V. cholerae. While the absolute levels of ompU and toxT
activation changed in the alanine mutants relative to the
original side-chain substitution mutants, five of six wing
mutants tested maintained preferential defects in toxT
activation; ToxR-K92A, ToxR-S93A ToxR-K98A, ToxR-
P101A and ToxR-R103A (Table 3), indicating these toxT-
specific defects were not side-chain-dependent.
The ToxR-D89A mutant was completely defective for
both ompU and toxT activation (Table 3) whereas the
original conservative mutant, ToxR-D89E, maintained
some activation of ompU and toxT (although it was pre-
ferentially toxT-defective, Fig. 1). All six alanine wing
mutants were stably expressed similar to wild-type ToxR
(data not shown).
Mutant ToxR-P101L in the putative wing domain of
ToxR is deficient in ToxR-TcpP cross-linking
Given that ToxR appears to play a supporting role for
activation of the toxT promoter by assisting direct activa-
tion by TcpP (Krukonis and DiRita, 2003), we tested our
various ToxR wing domain mutants that were preferen-
tially affected for toxT-lacZ activation, for their ability to
interact with TcpP in the membrane of V. cholerae. We
used a cross-linking capture ELISA protocol described
previously (Krukonis and DiRita, 2003) for assessing the
interaction of a number of ToxR mutant derivatives with
wild-type TcpP. For these experiments a V. cholerae
DtcpP strain (RY1) was first modified to harbour each toxR
allele of interest on the chromosome at the toxR locus.
The resulting strains were transformed with an HSV
Fig. 4. Gel-shift assays to assess promoter recognition by putative a-loop site-directed ToxR mutant proteins. V. cholerae membranes
prepared from a DtoxRDtcpP V. cholerae strain (EK459) expressing each mutant ToxR derivative (or wild-type ToxR-HA) were mixed at 0.05
and 0.25 mg ml-1 with radiolabelled ompU promoter DNA (A) or 0.2 and 1.0 mg ml-1 with toxT promoter DNA (B) before running samples in a
non-denaturing PAGE.
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epitope-tagged version of TcpP [encoded on pEK41
(Krukonis et al., 2000)]. The interaction between ToxR
and TcpP-HSV was assessed using V. cholerae mem-
branes harvested after a 6 h IPTG induction step to allow
for TcpP-HSV expression and membrane insertion.
We tested the ability of seven ToxR mutant proteins with
preferential defects in toxT activation to interact with wild-
type TcpP: ToxR-D73A, ToxR-D89E, ToxR-K92E, ToxR-
S93P, ToxR-K98E ToxR-P101L and ToxR-R103G (six of
which lie adjacent to or in the putative wing domain). As a
negative control we assessed the levels of interaction
between wild-type ToxR and a TcpP mutant protein, TcpP-
K101E, shown previously to be defective for ToxR inter-
action (Krukonis and DiRita, 2003).
Of the ToxR mutants tested, only ToxR-P101L (located at
the tip of the wing domain) showed reduced levels of
interaction with TcpP, with about 15% of wild-type levels of
interaction (Fig. 5). The level of ToxR-P101L interaction
with TcpP was as low as the previously characterized weak
interaction between ToxR and TcpP-K101E, although
ToxR-P101L was somewhat less stable than wild-type
ToxR and this may contribute to the reduced level of







ToxR-HA wild type 100  3.5 100  5.0
pSK (vector) 0.30  0.04 1.4  0.07
ToxR-D89E-HAa 78.9  4.7 29.8  11.1
ToxR-D89A-HA 1.2  0.23 1.7  0.1
ToxR-K92E-HAa 36.9  5.2 2.8  0.1
ToxR-K92A-HA 73.8  15.6 33.4  3.9
ToxR-S93P-HAa 33.9  4.6 8.1  0.6
ToxR-S93A-HA 104.0  6.9 21.4  3.4
ToxR-K98E-HAb 37.3  7.3 17.0  0.5
ToxR-K98A-HA 74.1  6.6 18.0  1.0
ToxR-P101L-HAa 34.0 + 11.8 11.2 + 0.8
ToxR-P101A-HA 52.2  16.0 10.3  0.4
ToxR-R103G-HAa 24.0 + 4.5 3.9 + 0.1
ToxR-R103A-HA 49.3  17.5 30.0  4.1
a. Data same as that shown in Fig. 1.
b. Data same as that shown in Table S1. Data are from at least two
experiments performed in triplicate.
Miller units measure in strains EK410 (O395 DtoxR ompU-lacZ) and
EK1072 (O395 DtoxR toxT-lacZ).
Fig. 5. Assessment of TcpP protein interaction by various ToxR mutant proteins that preferentially affect toxT transcription. V. cholerae
membranes from cells expressing each ToxR mutant derivative were assessed for their ability to interact with wild-type TcpP-HSV or
TcpP-K101E. ToxR mutant proteins were expressed from the chromosomal toxR locus while TcpP-HSV was expressed from the
IPTG-inducible plasmid pEK41 in a DtcpP V. cholerae background. TcpP-HSV was captured to 96-well microtiter plates using an anti-HSV
monoclonal antibody. TcpP capture was assessed by probing the wells with an anti-TcpP polyclonal antibody (Krukonis and DiRita, 2003;
Matson and DiRita, 2005), while ToxR co-capture was assessed by probing parallel wells with an anti-ToxR polyclonal antibody. Levels of each
ToxR mutant protein and TcpP-HSV were assessed by Western blot on the same protein extracts used for cross-linking. Statistical
comparisons were made using the student’s t-test and compare samples relative to a strain expressing wild-type ToxR and wild-type
TcpP-HSV. *P = 0.05, **P < 0.02.
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ToxR/TcpP interaction (Fig. 5). One other mutant, ToxR-
D89E, showed a trend towards decreased TcpP interac-
tion, but the defect did not reach statistical significance
(Fig. 5, P = 0.07). All other ToxR mutants maintained wild-
type (or in some cases increased) levels of TcpP interaction
(Fig. 5), despite their reduced levels of toxT-lacZ activation
(Fig. 1, Tables 2 and S1).
As the ToxR/TcpP capture assay is dependent upon
lysine-mediated cross-linking, we established a second
assay for ToxR/TcpP interaction, a membrane-bound
ToxR and TcpP bacterial two-hybrid reporter system.
This system is based on the reconstitution of a split
adenylate cyclase enzyme of Bordetella pertussis,
which upon ToxR/TcpP interaction brings the two Cya
fragments together leading to cAMP generation and
increased b-galactosidase production in Escherichia coli
(Karimova et al., 1998; 2005). Unlike the cross-linking
assay described above, this assay does not rely upon
primary amines for DSP-mediated cross-linking. Using
the bacterial two-hybrid system we were unable to
detect a significant defect in ToxR-P101L interaction with
TcpP (Fig. 6), suggesting the defect in interaction in the
cross-linking assay may be due to alterations in the ori-
entation of lysines in the vicinity of P101.
These data indicate that ToxR-P101L maintains interac-
tion with TcpP, but in an altered form as compared with
wild-type ToxR. It should be noted that the bacterial two-
hybrid assay is performed using plasmids expressing ToxR
and TcpP in E. coli and the levels of ToxR-P101L may be
higher than was achieved in V. cholerae when ToxR-P101L
was expressed from its normal chromosomal locus. None
of the other ToxR wing domain mutants tested had a defect
in the bacterial two-hybrid assay (Fig. 6).
Two previously characterized TcpP mutants, TcpP-L96S
and TcpP-I97T, which failed to interact with ToxR in the
capture assay (Krukonis and DiRita, 2003), were com-
pletely defective for ToxR/TcpP interaction in the bacterial
two-hybrid assay (Fig. 6A), while a third TcpP mutant,
TcpP-K101E, completely defective for ToxR cross-linking
[Fig. 5 (Krukonis and DiRita, 2003)], was only partially
defective in the bacterial two-hybrid assay (Fig. 6A, P = 0.
035). This mutant may have lost some level of cross-
linking in the capture assay (Fig. 5) as a result of
substitution of the lysine, which carries a primary amine
group. While TcpP-L96S and TcpP-I97T were less stable
than wild-type TcpP in this system, it should be noted that
some ToxR mutants (ToxR-S93P and ToxR-K98E) were
similarly less stable and maintained robust interaction
with TcpP (Fig. 6B and D).
Discussion
This manuscript set out to address the differential roles for
ToxR at two distinct V. cholerae promoters, ompU and
toxT. Using an ompU-sacB fusion-based selection strat-
egy, we identified a number of residues in ToxR required
for full activation of the ompU promoter (Fig. 1). While
several of these mutations severely affected ompU pro-
moter binding, those in the putative a-loop of ToxR (Fig. 2)
had less dramatic DNA-binding defects (Fig. 3A). One
particular a-loop mutant, ToxR-V71A, was nearly com-
pletely defective for ompU activation (3% of wild type)
while it maintained intermediate levels of toxT activation
(15% of wild type, Fig. 1). Thus, this residue in the a-loop
may be particularly critical for engagement of the RNAP
machinery at the ompU promoter. The fact that one other
a-loop mutant, ToxR-R65Q, had an ompU promoter-
binding defect similar to ToxR-V71A (Fig. 3A), yet main-
tained 35% ompU activation also supports the hypothesis
that V71 has a specific role in ToxR-mediated ompU
activation. The importance of residues in the a-loop in
ompU activation was reiterated with the generation of
site-directed a-loop mutations in which one additional
a-loop alanine substitution, ToxR-F69A, led to a defect in
ompU activation (Table 2), but had no effect on ompU
promoter binding (Fig. 4A). Residue E39 in the neighbour-
ing helix a1 (Fig. 2A and B) also appears to contribute
specifically to ompU activation (Table S1) and may be part
of an RNAP interaction patch for ompU activation (Fig. 7).
It should be noted that some mutations in the a-loop
affected both ompU and toxT activation (ToxR-R65A,
ToxR-G68A and ToxR-S74A) and two mutants, ToxR-
R65Q and ToxR-D73A, affected toxT activation preferen-
tially over ompU (Fig. 1 and Table 2). Thus the a-loop is
not exclusively important for ompU activation. However,
the ToxR-V71A mutant indicates this residue is particularly
important for ompU activation as no other a-loop mutant
tested had a comparable toxT activation defect (97%
defective). Other members of the OmpR/PhoB family
of winged-HTH activators also have activation-specific
mutations identified in their a-loops (Pratt and Silhavy,
1994; Kato et al., 1995). In some cases, suppressor muta-
tions in the gene encoding a component of RNA poly-
merase can rescue the activation-defective OmpR/PhoB
family member (Kato et al., 1996).
Eight ToxR substitution mutants with intermediate
defects in ompU-lacZ expression (ToxR-R65Q, ToxR-
D73A, ToxR-D89E, ToxR-K92E, ToxR-S93P, ToxR-K98E,
ToxR-P101L and ToxR-R103G) showed preferential
defects in toxT-lacZ expression relative to ompU-lacZ
expression. Six of eight substitutions affect residues adja-
cent to or within the putative wing domain of the winged-
HTH domain of ToxR. The wing domain in this family of
proteins has been shown in some instances to be
involved in DNA binding, while in other cases it plays a
role in protein–protein interactions (Littlefield and Nelson,
1999; Blanco et al., 2002; Krukonis and DiRita, 2003;
Yamane et al., 2008). When involved in DNA binding, the
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wing binds the minor groove of the DNA helix while the
DNA-recognition a-helix (a3, Fig. 2A) recognizes the
major groove (Blanco et al., 2002; Yamane et al., 2008).
Our findings suggest the wing domain of ToxR is involved
in DNA binding (Fig. 3) and may also play a role in TcpP
interaction (Fig. 5). We hypothesize that ToxR interaction
with TcpP allows ToxR to facilitate activation of the toxT
promoter. One ToxR wing mutant that affected toxT acti-
vation preferentially, ToxR-P101L, was defective for this
ToxR/TcpP interaction as assessed by a cross-linking
assay, with ToxR-P101L expressed from its chromosomal
locus (Fig. 5). On the other hand, a plasmid-based ToxR/
Fig. 6. Assessment of ToxR/TcpP interaction by various ToxR and TcpP mutants using an adenylate cyclase-based membrane-anchored
bacterial two-hybrid system.
A. Interaction between wild-type TcpPH fused to the cya25 fragment of B. pertussis CyaA and ToxRS fused to the cya18 fragment of CyaA
were assessed in strain BTH101. Interaction was determined by measuring b-galactosidase activity produced as a result of reconstitution of a
functional adenylate cyclase enzyme. Known non-interacting mutants of TcpP were fused to cya25 as controls. As additional controls
cya18-ToxR and cya25-TcpP alone were tested.
B. Western blot analysis of ToxR mutant derivatives fused to cya18.
C. Western blot analysis of wild-type ToxR and EpsM fused to cya18.
D. Western blot analysis of TcpP fused to cya25. All Western blots were probed with rabbit anti-CyaA antibodies (Santa Cruz Biotechnology).
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TcpP bacterial two-hybrid assay revealed no significant
defect for ToxR-P101L/TcpP interaction (Fig. 6). It was
notable that wild-type ToxR consistently generated high
levels of cAMP in the bacterial two-hybrid assay, resulting
in lacZ expression levels ranging from 898–2922 Miller
Units over 42 measurements, while ToxR-P101L gave
more variable lacZ expression levels, ranging from 195–
2975 Miller Units over 27 measurements (Fig. 6A).
Together we take these data to indicate that the ToxR-
P101L mutant likely presents a slightly altered conforma-
tion of the ToxR wing domain that affects the ToxR/TcpP
cross-linking assay more dramatically than the bacterial
two-hybrid assay. We hypothesize that in the former
assay, this altered wing conformation affects the presen-
tation of a neighbouring lysine residue, which is involved
in ToxR/TcpP cross-linking. In support of the hypothesis
that the wing of ToxR may interact with TcpP, we have
recently uncovered a number of residues in the wing
domain of ToxR that affect ToxR/TcpP interactions in
the bacterial two-hybrid assay (S.J. Morgan and E.S.
Krukonis, unpubl. obs.).
Because no other wing mutants tested had a significant
defect in TcpP interaction by either assay, the toxT-
preferential defects of the other ToxR wing substitutions
may reflect their slightly greater defects in toxT promoter
binding as compared with ompU binding (Figs 3 and S1)
and/or some other aspect of promoter interaction required
for full toxT activation. ToxR may have a lower affinity for
the toxT promoter than the ompU promoter, thus the
reduced DNA-binding activity of these ToxR wing mutants
may largely explain their preferential defects in toxT
activation. Modest reductions in DNA-binding affinity may
also preferentially affect toxT-lacZ expression in V. chol-
erae relative to ompU-lacZ as ToxR must displace the
global regulator H-NS bound to the toxT promoter (Nye
et al., 2000). Alternatively, by affecting the wing domain,
these mutants may be altered in their interaction with the
minor groove of the DNA in a way that slightly changes the
orientation of ToxR on the DNA rather than leading to a
major defect in DNA-binding affinity. This could adversely
affect the ability of ToxR to efficiently function with TcpP to
facilitate toxT expression. It remains less clear why the
ToxR a-loop mutant derivatives, ToxR-R65Q and ToxR-
D73A, showed toxT-specific activation defects (Fig. 1 and
Table 2), but their toxT activation defects were < twofold of
their ompU activation defects, making them the least dra-
matic of the toxT-specific defects. The ToxR-D73 side-
chain is predicted to be oriented towards the wing domain
when modelled on other winged-HTH transcription factors
(Fig. 2C), although assignment of side-chain orientation
in loop regions is tentative. If oriented towards the wing
domain, D73 may function along with wing residues of
ToxR to enhance TcpP-mediated toxT activation. R65
maintains some toxT-specific defects even when changed
to alanine or leucine (Table 2 and Table S1), although
the preference diminishes with these other side-chain
substitutions. When bound to the toxT promoter with a3 in
the major groove it is possible that R65 can contribute to
functions specific for TcpP-dependent activation as this
side-chain is predicted to extend to the edge of the a-loop
(Fig. 2C) and potentially participate in interactions prima-
rily involving the face of ToxR containing the wing domain.
Our modelling of ToxR bound to DNA and results with
other PhoB/OmpR family members (Blanco et al., 2002;
Yamane et al., 2008) indicate that the a-loop sits ‘side
saddle’ on the DNA (Fig. 7) and interacts with RNAP from
Fig. 7. Model for differential activation of the ompU and toxT promoters of V. cholerae by ToxR.
A. ToxR directly activates the ompU promoter in the absence of TcpP using residues F69 and V71 of the a-loop, and possibly E39 of a3, to
stimulate RNA polymerase transcription.
B. ToxR activates the toxT promoter in conjunction with TcpP by facilitating the ability of TcpP to interact with RNA polymerase. At the toxT
promoter, ToxR and TcpP may interact via wing–wing contacts between the proteins. Thus, in this model, ToxR is inverted in its binding
orientation on the DNA relative to the ompU promoter to present the wing face of ToxR to TcpP. Both promoters are shown from a backside
view to allow easier visualization of the side-chains that contribute preferentially to ompU (magenta) or toxT (orange) activation. The DNA
template used is from the structure of PhoB bound to DNA (Yamane et al., 2008).
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that position. Thus, residues that extend in one direction
from the a-loop like F69 and V71 (Fig. 2B) may interact
with RNAP while those that extend in the other direction,
like R65 and D73 may interact with other components of
the activation complex.
In all, these studies define residue V71 of the a-loop of
ToxR as being critical for activation of the ompU promoter
and F69 playing a supporting role in ompU activation.
Residues adjacent to and within the wing domain of ToxR
also affect ompU activation, but in a number of cases
more strongly affect toxT activation. Why some of these
ToxR mutations affect toxT more dramatically than ompU
remains to be determined. In at least one case, ToxR-
P101L, presentation of the wing domain for ToxR/TcpP
interaction was affected (Fig. 5). For the remainder of the
ToxR derivatives preferentially defective for toxT activa-
tion, there was no statistically significant defect in TcpP
interaction. Thus, the wing domain of ToxR appears to
play a role on both ompU and toxT activation, but perhaps
a dual role in toxT activation, DNA binding and TcpP
interaction. It is notable that the mutation affecting ToxR/
TcpP cross-linking was ToxR-P101L, which is predicted to
perturb the structure of the wing domain by eliminating
the proline turn residue at the tip of the wing. Mutations
in the wing domain of TcpP (also an OmpR/PhoB family
member) have been shown previously to affect ToxR
interaction (Krukonis and DiRita, 2003). Thus, we present
a model where the wing domains of ToxR and TcpP are
oriented towards each other on the toxT promoter (Fig. 7).
ToxR binds the toxT promoter near an inverted repeat
element (Higgins and DiRita, 1994; Krukonis et al., 2000).
However, we have evidence that ToxR may bind to an
imperfect direct repeat that extends into the 5′ half of this
inverted repeat element, rather than binding the inverted
repeat element itself (T. Goss and E.S. Krukonis, unpubl.
obs.). Thus, we model ToxR on the toxT promoter as a
head-to-tail dimer with its wing domain oriented towards
TcpP (Fig. 7B). At the ompU promoter, we orient the pro-
moter proximal ToxR molecule with residues F69 and V71
of the a-loop oriented towards the promoter for interaction
with RNA polymerase (Fig. 7A). Orientation of the remain-
ing ToxR molecules on the ompU promoter is speculative
and future experiments will test the model we propose for
ToxR binding throughout the ompU promoter (Crawford
et al., 1998; Li et al., 2000).
Experimental procedures
Bacterial strains and plasmids
A list of bacterial strains and plasmids is provided in Table 1.
V. cholerae were grown in modified LB (with 5 g l-1 NaCl
rather than 10 g l-1) with 100 mg ml-1 streptomycin and
100 mg ml-1 ampicillin or 25 mg ml-1 chloramphenicol as
appropriate.
Construction of an HA-epitope tagged toxR allele
toxR from V. cholerae strain O395 was PCR amplified from
chromosomal DNA using a primer with a BamHI restriction
site and including the toxR ribosomal binding site (primer 5′
ToxR-HA) and a 3′ XhoI restriction site (primer 3′ ToxR-HA)
to allow in-frame ligation into the HA-tagging vector
pcDNA3-HA (Inohara et al., 1998). The resulting C-terminally
HA-tagged toxR allele was confirmed to encode wild-type
toxR by sequencing. The toxR-HA allele was then liberated
from pcDNA3-HA by BamHI and ApaI digestion and ligated
into the expression vector pSK Bluescript (Invitrogen) for
expression in V. cholerae. Primers for these studies are listed
in Table S2.
Isolation of sucrose-resistant toxR alleles using an
ompU-sacB selection
The toxR-HA allele was subjected to random Taq
polymerase-mediated mutagenesis by standard PCR ampli-
fication for 20 rounds of amplification using primers 5′
ToxR-HA and 3′ HA-tag ApaI (Table S2). The toxR-HA mutant
pool was cut with BamHI and ApaI and ligated into fresh pSK
Bluescript digested with BamHI and ApaI. Three pools of
~ 300–400 clones were generated and used to transform the
V. cholerae DtoxR ompU-sacB strain, EK406. Transformants
were plated onto LB plates containing 5% sucrose,
100 mg ml-1 streptomycin and 100 mg ml-1 ampicillin (to select
for pSK Bluescript) and 100 mM IPTG to induce toxR-HA
expression. Within the three pools, the percentage of mutant
pSK-toxR-HA alleles that resulted in sucrose resistance in
strain EK406 was, 2.5%, 4.5% and 6.25% respectively. About
160 colonies from the three pools were picked and screened
individually for ToxR-HA expression by Western blot analysis
after growth of the strain for 3 h in 3 ml LB + 100 mM IPTG
(data not shown). Those that expressed significant amount of
full-length ToxR-HA as assessed by anti-HA antibody, were
studied further. This amounted to about 25–35% of the total
sucrose-resistant clones analysed. Those mutants defective
for ompU-sacB activation, that expressed full-length ToxR-
HA, were sent for sequencing at the University of Michigan
Sequencing Core.
Measuring transcriptional activation activity of ToxR-HA
derivatives
pSK-toxR-HA derivatives encoding various toxR-HA alleles
were transformed into the V. cholerae DtoxR ompU-lacZ
reporter strain EK410 and the DtoxR toxT-lacZ reporter strain
EK1072. The latter is a DtoxR derivative of a previously
constructed O395 toxT-lacZ strain, a kind gift from Dr Claudia
Häse (Häse and Mekalanos, 1998 #993). Reporter strains
harbouring the various ToxR-HA derivatives were grown in
triplicate overnight at 30°C and then diluted 1:50 and grown
for 3–4 h at 30°C in the presence of 100 mg ml-1 streptomycin,
100 mg ml-1 ampicillin and 100 mM IPTG. Cells were har-
vested and 20 ml or 100 ml were used in a standard b-
galactosidase assay {Miller, 1972 #35}. Measurements of
ompU and toxT activation for each ToxR-HA mutant derivative
were assessed in at least two separate experiments.
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DNA gel mobility shift assays
Promoter-binding assays were performed essentially as
described previously (Krukonis et al. 2000 #1392). The mem-
branes used were from strain EK459 (DtoxRDtcpP) carrying
each pSK-toxR-HA allele and induced for 4–5 h at 30°C in
500 ml LB pH = 6.5 with 100 mM IPTG. Increasing concen-
trations of membrane were mixed with either an ompU
promoter probe extending from -211 to +22 relative to the
transcriptional start site, a toxT promoter probe extending
from -172 to +45 or a negative control toxT promoter probe
extending from -46 to +45 [lacking the ToxR-binding site
(Higgins and DiRita, 1994)]. Probes were labelled by Klenow
fill-in of BamHI or SalI digested plasmids with a-32P-dCTP
and 3000 cpm of labelled probe were used in each reaction.
Relative levels of each ToxR mutant protein were assessed
using anti-HA monoclonal antibody (Covance), anti-HA poly-
clonal antibody (Covance) or anti-ToxR polyclonal antibody.
Samples normalized to the same relative concentrations
used in the gel-shift assay were boiled in SDS sample buffer
and run in a 12% SDS-PAGE gel.
ToxR/TcpP-HSV capture assay
Vibrio cholerae RY1 with various toxR alleles recombined at
the normal toxR locus were transformed with plasmids
expressing wild-type TcpP-HSV or the ToxR-interacting
mutant TcpP-K101E. Strains were diluted 1:50 from an
overnight culture at 30°C and grown for 4–6 h at 30°C in
500 ml LB containing 100 mg ml-1 streptomycin, 25 mg ml-1
chloramphenicol and 100 mM IPTG. Membranes harbouring
ToxR and TcpP-HSV proteins of interest were prepared
(Miller et al., 1987 #3) and dialysed into HEPES-buffered
saline (HBS, 20 mM HEPES pH = 7.0, 150 mM NaCl).
Three to five mg ml-1 membrane proteins were cross-linked
using a 15-fold molar excess of DSP (Pierce) for 30′ at
room temp, blocked with 50 mM Tris pH = 7.4 and then
solubilized in 1% Triton X-100 (Bio-Rad). The molarity of
dialysed membrane preparations was estimated by mea-
suring the protein concentration and assuming a 50 kD
average protein size in the total membrane extract. After
sonication on ice (3 ¥ 5 seconds), 50 ml membrane extracts
was added to microtiter plates coated with mouse anti-HSV
antibody (Novagen, coated at 1:500 dilution in PBS) and
binding proceeded overnight at 4°C. After washing five
times with PBS, wells were incubated with 50 ml a 1:100
dilution of rabbit anti-TcpP antibody or a 1:1000 dilution
rabbit anti-ToxR antibody. Primary antibody incubation pro-
ceeded from 3 h overnight at 4°C. After five washes with
PBS, wells were then incubated with a 1:3000 dilution of
goat anti-rabbit-AP conjugated secondary antibody (Zymed)
and binding was revealed by addition of 100 ml of the
colorimetric substrate PNPP (Sigma) at 4 mg ml-1 follow-
ing sequential washing with PBS (four times) Tris-buffered
saline (100 mM Tris pH = 8.0, 150 mM NaCl, one wash).
Plates were read at ABS405. Relative levels of each ToxR
mutant protein were assessed using an anti-ToxR polyclonal
antibody at a 1:1000 dilution. Relative levels of TcpP-HSV in
each strain were assessed using an anti-HSV monoclonal
antibody (Novagen) at a 1:5000 dilution. The amount of
TcpP-HSV or ToxR captured is presented as % of wild type
after subtracting out the background signal obtained for
each protein in the absence of TcpP-HSV (using the
pMMB207 empty vector). Samples diluted on the same day
to the same relative concentrations used in the capture
assay were boiled in SDS sample buffer and run in a 12%
SDS-PAGE gel for Western blot analysis of protein levels in
the extracts. Statistical analysis was performed using the
student’s t-test comparing six or nine measurements rela-
tive to the strain expressing wild-type ToxR and wild-type
TcpP-HSV.
ToxR/TcpP bacterial two-hybrid system
ToxRS and EpsM were PCR amplified from chromosomal
DNA and cloned into the pUT18c vector (Karimova et al.,
2001) 3′ of the cya18 fragment in DHM1. TcpPH was PCR
amplified from chromosomal DNA and cloned into the pKT25
vector (Karimova et al., 2001) 3′ of the cya25 fragment in
DHM1. Point mutations were created in ToxR and TcpP using
site-directed mutagenesis (primers are listed in Table S2).
Plasmids were transformed into the reporter strain BTH101
and grown at 37°C in the presence of 100 mg ml-1 ampicillin
and 30 mg ml-1 kanamycin. Cultures were induced 16 h at
30°C in LB broth in the presence of 100 mg ml-1 ampicillin,
30 mg ml-1 kanamycin 0.5 mM and IPTG. 20 ml of culture was
used in a standard b-galactosidase assay (Miller, 1972) in a
minimum of three separate experiments with three replicates
each. Stability of ToxR and TcpP mutants was determined by
transforming the cya18-ToxRS mutant plasmid with pKT25 or
cya25-TcpP mutant plasmid with pUT18c into BTH101. Cul-
tures were induced 16 h at 30°C in LB broth in the presence
of 100 mg ml-1 ampicillin, 30 mg ml-1 kanamycin, 0.5 mM
IPTG and 1 mM cAMP. Samples normalized to the same
relative concentrations by OD600 were boiled in SDS-sample
buffer and run in a 10% SDS-PAGE gel. Samples were
probed with anti-CyaA rabbit polyclonal antibody (Santa Cruz
Biotechnology).
ToxR mutant modelling
Using a newly developed program I-TASSER (Zhang, 2008;
2009; Roy et al., 2010), we threaded the ToxR sequence
onto winged-HTH family members with solved structures.
I-TASSER made a secondary structure sequence prediction
for ToxR and threaded that onto to several best matches in the
PDB, compiling the best matching fragments from each struc-
ture. In creating the ToxR model, I-TASSER used parts of YycF
(from Bacillus subtilis), OmpR (E. coli ), MtrA (Mycobacterium
tuberculosis), RegX3 (M. tuberculosis), ArsR (Helicobacter
pylori ) and VicRc (Enterococcus faecalis) as the top 10
threading templates (results at http://zhanglab.ccmb.
med.umich.edu/I-TASSER/output/S57294/). It then compiled
these best fit pieces and performed energy/hydrogen bonding
optimization. The best fit of the ToxR model is to YycF, with
25% sequence identity (with PhoB of E. coli as the third best
fit). Using the protein structure analysis program Chimera
(Pettersen et al., 2004), several key residues of ToxR were
highlighted to show the predicted orientation of their side-
chains to gain insights into their potential effects on ToxR
function.
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